ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry
|
|
- Mitchell Short
- 6 years ago
- Views:
Transcription
1 ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data Item Name Data Item Number NPCR Collect Recommendation Code Suggested Default Value Record Type 10 R A Patient ID Number 20 R (Central Registry) Patient System ID-Hosp 21 Registry Type 30 FIN Coding System 35 Reserved Registry ID 40 R NPI--Registry ID 45 NAACCR Record Version 50 R Tumor Record Number 60 Addr at DX--City 70 R Addr at DX--State 80 R County at DX 90 R Addr at DX--Postal Code 100 R Addr at DX--Country 102 R USA Census Tract 1970/80/ RH* Census Cod Sys 1970/80/ RH* Census Tract R CR Census Tract R Census Tract Cod Sys--Alt 140 CR Census Tr Poverty Indictr 145 Marital Status at DX 150 Race R Race R Race R Race R Race R Race Coding Sys--Current 170
2 Race Coding Sys--Original 180 Spanish/Hispanic Origin 190 R NHIA Derived Hisp Origin 191 D CR IHS Link 192 R* Race--NAPIIA(derived API) 193 R Computed Ethnicity 200 R Computed Ethnicity Source 210 R Sex 220 R Age at Diagnosis 230 R Date of Birth 240 R Date of Birth Flag 241 R Birthplace 250 RH Birthplace--State 252 R* Birthplace--Country 254 R* Religion 260 Census Occ Code R* CR Census Ind Code Census Ind Code R* CR Census Occ Code Occupation Source 290 R* Industry Source 300 R* Text--Usual Occupation 310 R* Text--Usual Industry 320 R* Census Occ/Ind Sys R* Tobacco History 340 Alcohol History 350 Family History of Cancer 360 CR Census Block Group CR Census Block Group Census Tr Cert 1970/80/ RH* CR Census Tr Certainty R CR GIS Coordinate Quality 366 R* CR Census Tr Certainty R CR Census Block Grp See end of the table for ASCR specific location
3 Reserved Sequence Number--Central 380 R Date of Diagnosis 390 R Date of Diagnosis Flag 391 R Primary Site 400 R Laterality 410 R Morph--Type&Behav ICD-O Histology (92-00) ICD-O RH Behavior (92-00) ICD-O RH Date of Mult Tumors Flag 439. Grade 440 R Grade Path Value 441 R* Ambiguous Terminology DX 442. Date Conclusive DX 443. Mult Tum Rpt as One Prim 444. Date of Mult Tumors 445. Multiplicity Counter 446. Number of Tumors/Hist 447 Date Conclusive DX Flag 448. Grade Path System 449 R* Site Coding Sys--Current 450 R 5 (ICD-O, third edition) Site Coding Sys--Original (ICD-O, third edition) Morph Coding Sys--Current 470 R 8 Morph Coding Sys--Originl Diagnostic Confirmation 490 R Type of Reporting Source 500 R Casefinding Source 501 R Screening Date 510 Screening Result 520 Morph--Type&Behav ICD-O Histologic Type ICD-O R Behavior Code ICD-O R Reserved Reporting Hospital FAN 538
4 Reporting Facility 540 R NPI--Reporting Facility 545 R* Accession Number--Hosp 550 Sequence Number--Hospital 560 Abstracted By 570. Date of 1st Contact 580 R Date of 1st Contact Flag 581 R Date of Inpt Adm 590. Date of Inpt Adm Flag 591. Date of Inpt Disch 600. Date of Inpt Disch Flag 601. Inpatient Status 605. Class of Case 610 R Year First Seen This CA 620 Primary Payer at DX 630 R* Inpatient/Outpt Status 640 Presentation at CA Conf 650 Date of CA Conference 660 RX Hosp--ASA Class 665. RX Hosp--Surg App RX Hosp--Surg Prim Site 670. RX Hosp--Scope Reg LN Sur 672. RX Hosp--Surg Oth Reg/Dis 674. RX Hosp--Reg LN Removed 676. RX Hosp--Surg Timing 678. Reserved RX Hosp--Radiation 690. RX Hosp--Chemo 700. RX Hosp--Hormone 710. RX Hosp--BRM 720. RX Hosp--Other 730. RX Hosp--DX/Stg Proc 740. RX Hosp--Screen/BX Proc1 742 RX Hosp--Screen/BX Proc2 743
5 RX Hosp--Screen/BX Proc3 744 RX Hosp--Screen/BX Proc4 745 RX Hosp--Surg Site RX Hosp--Scope Reg RX Hosp--Surg Oth Reserved SEER Summary Stage R+ SEER Summary Stage RH Loc/Reg/Distant Stage 770 Extent of Disease 10-Dig 779 EOD--Tumor Size 780 EOD--Extension 790 EOD--Extension Prost Path 800 EOD--Lymph Node Involv 810 Regional Nodes Positive 820 R Regional Nodes Examined 830 R EOD--Old 13 Digit 840 EOD--Old 2 Digit 850 EOD--Old 4 Digit 860 Coding System for EOD TNM Path T 880 Required, when available (NPCR) TNM Path N 890 Required, when available (NPCR) TNM Path M 900 Required, when available (NPCR) TNM Path Stage Group 910 Required, when available (NPCR) TNM Path Descriptor 920 Required, when available (NPCR) TNM Path Staged By 930 TNM Clin T 940 Required, when available (NPCR) TNM Clin N 950 Required, when available (NPCR) TNM Clin M 960 Required, when available (NPCR) TNM Clin Stage Group 970 Required, when available (NPCR) TNM Clin Descriptor 980 Required, when available (NPCR) TNM Clin Staged By 990. TNM Other T 1000 TNM Other N 1010
6 TNM Other M 1020 TNM Other Stage Group 1030 TNM Other Staged By 1040 TNM Other Descriptor 1050 TNM Edition Number 1060 Required, when available (NPCR) Other Staging System 1070 Date of 1st Positive BX 1080 Site of Distant Met Site of Distant Met Site of Distant Met Pediatric Stage 1120 Pediatric Staging System 1130 Pediatric Staged By 1140 Tumor Marker Tumor Marker Tumor Marker Reserved Lymph-vascular Invasion 1182 RS Reserved RX Date Surgery 1200 R RX Date Surgery Flag 1201 R RX Date Radiation 1210 RS RX Date Radiation Flag 1211 RS RX Date Chemo 1220 RS RX Date Chemo Flag 1221 RS RX Date Hormone 1230 RS RX Date Hormone Flag 1231 RS RX Date BRM 1240 RS RX Date BRM Flag 1241 RS RX Date Other 1250 RS RX Date Other Flag 1251 RS Date of Initial RX SEER 1260 R# Date of Initial RX SEER Flag 1261 R# Date of 1st Crs RX CoC 1270 R#
7 Date of 1st Crs Rx CoC Flag 1271 R# RX Date DX/Stg Proc RX Date Dx/Stg Proc Flag RX Summ--Treatment Status 1285 RS# RX Summ--Surg Prim Site 1290 R RX Summ--Scope Reg LN Sur 1292 R RX Summ--Surg Oth Reg/Dis 1294 R RX Summ--Reg LN Examined Reserved RX Summ--Surgical Approch RX Summ--Surgical Margins RX Summ--Reconstruct 1st Reason for No Surgery 1340 R RX Summ--DX/Stg Proc 1350 RX Summ--Radiation 1360 RS RX Summ--Rad to CNS 1370 RX Summ--Surg/Rad Seq 1380 RS RX Summ--Chemo 1390 RS RX Summ--Hormone 1400 RS RX Summ--BRM 1410 RS RX Summ--Other 1420 RS Reason for No Radiation 1430 RS Reason for No Chemo 1440 Reason for No Hormone 1450 RX Coding System--Current 1460 R 06 (FORDS) Protocol Eligibility Stat 1470 Protocol Participation 1480 Referral to Support Serv 1490 First Course Calc Method 1500 Rad--Regional Dose: CGY Rad--No of Treatment Vol Rad--Elapsed RX Days 1530 Rad--Treatment Volume Rad--Location of RX 1550.
8 Rad--Intent of Treatment 1560 Rad--Regional RX Modality 1570 RS Rad--RX Completion Status 1580 Rad--Local Control Status 1590 Chemotherapy Field Chemotherapy Field Chemotherapy Field Chemotherapy Field RX Summ--Systemic/Sur Seq 1639 RS RX Summ--Surgery Type RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Surg Site RX Summ--Scope Reg RX Summ--Surg Oth Reserved Subsq RX 2nd Course Date Subsq RX 2ndCrs Date Flag Subsq RX 2nd Course Codes Subsq RX 2nd Course Surg Subsq RX 2nd Course Rad Subsq RX 2nd Course Chemo Subsq RX 2nd Course Horm Subsq RX 2nd Course BRM Subsq RX 2nd Course Oth Subsq RX 2nd--Scope LN SU Subsq RX 2nd--Surg Oth Subsq RX 2nd--Reg LN Rem Subsq RX 3rd Course Date Subsq RX 3rdCrs Date Flag Subsq RX 3rd Course Codes Subsq RX 3rd Course Surg 1691.
9 Subsq RX 3rd Course Rad Subsq RX 3rd Course Chemo Subsq RX 3rd Course Horm Subsq RX 3rd Course BRM Subsq RX 3rd Course Oth Subsq RX 3rd--Scope LN Su Subsq RX 3rd--Surg Oth Subsq RX 3rd--Reg LN Rem Subsq RX 4th Course Date Subsq RX 4thCrs Date Flag Subsq RX 4th Course Codes Subsq RX 4th Course Surg Subsq RX 4th Course Rad Subsq RX 4th Course Chemo Subsq RX 4th Course Horm Subsq RX 4th Course BRM Subsq RX 4th Course Oth Subsq RX 4th--Scope LN Su Subsq RX 4th--Surg Oth Subsq RX 4th--Reg LN Rem Subsq RX 5th Course Date 1720 Subsq RX 5th Course Codes 1730 Subsq RX 5th Course Surg 1731 Subsq RX 5th Course Rad 1732 Subsq RX 5th Course Chemo 1733 Subsq RX 5th Course Horm 1734 Subsq RX 5th Course BRM 1735 Subsq RX 5th Course Oth 1736 Subsq RX 5th--Scope LN Su 1737 Subsq RX 5th--Surg Oth 1738 Subsq RX 5th--Reg LN Rem 1739 Reserved Subsq RX--Reconstruct Del Date of Last Contact 1750 R
10 Date of Last Contact Flag 1751 R Date of Death--Canada Date of Death--CanadaFlag Vital Status 1760 R Cancer Status Quality of Survival Follow-Up Source 1790 R* CR Follow-up Source Central 1791 R Next Follow-Up Source Addr Current--City Addr Current--State Addr Current--Postal Code Addr Current--Country 1832 Reserved County--Current Follow-Up Contact--City Follow-Up Contact--State Follow-Up Contact--Postal Follow-Up Contact--Country 1847 Unusual Follow-Up Method Recurrence Date--1st Recurrence Date--1st Flag Recurrence Distant Sites 1870 Recurrence Distant Site Recurrence Distant Site Recurrence Distant Site Recurrence Type--1st Recurrence Type--1st--Oth 1890 Reserved Cause of Death 1910 R 0000 (live) ICD Revision Number 1920 R 0 (live) Autopsy 1930 R 0 (live) Place of Death 1940 RH Place of Death--State 1942 R
11 Place of Death--Country 1944 R* Site (73-91) ICD-O Morph (73-91) ICD-O Histology (73-91) ICD-O Behavior (73-91) ICD-O Grade (73-91) ICD-O ICD-O-2 Conversion Flag Over-ride SS/NodesPos Over-ride SS/TNM-N Over-ride SS/TNM-M Over-ride SS/DisMet Over-ride Acsn/Class/Seq Over-ride HospSeq/DxConf Over-ride CoC-Site/Type Over-ride HospSeq/Site Over-ride Site/TNM-StgGrp Over-ride Age/Site/Morph 1990 R Over-ride SeqNo/DxConf 2000 R Over-ride Site/Lat/SeqNo 2010 R Over-ride Surg/DxConf 2020 R Over-ride Site/Type 2030 R Over-ride Histology 2040 R Over-ride Report Source 2050 R Over-ride Ill-define Site 2060 R Over-ride Leuk, Lymphoma 2070 R Over-ride Site/Behavior 2071 R Over-ride Site/EOD/DX Dt Over-ride Site/Lat/EOD Over-ride Site/Lat/Morph 2074 R Reserved CRC CHECKSUM Date Case Initiated Date Case Completed Date Case Completed--CoC 2092.
12 Date Case Last Changed Date Case Report Exported 2110 R CR Date Case Report Received 2111 R CR Date Case Report Loaded 2112 R Date Tumor Record Availbl 2113 R Future Use Timeliness Future Use Timeliness ICD-O-3 Conversion Flag 2116 R SEER Coding Sys--Current D Coding Manual SEER Coding Sys--Original CoC Coding Sys--Current CoC Coding Sys--Original Subsq Report for Primary 2160 Vendor Name SEER Type of Follow-Up SEER Record Number Diagnostic Proc Reserved State/Requestor Items Name--Last 2230 R Name--First 2240 R Name--Middle 2250 R Name--Prefix Name--Suffix Name--Alias 2280 R Name--Spouse/Parent Medical Record Number 2300 R Military Record No Suffix Social Security Number 2320 R Addr at DX--No & Street 2330 R Addr at DX--Supplementl 2335 R Addr Current--No & Street CR Latitude 2352 R* CR Longitude 2354 R*
13 Addr Current--Supplementl Telephone DC State 2370 DC State File Number 2380 R Name--Maiden 2390 R Follow-Up Contact--No&St Follow-Up Contact--Suppl Follow-Up Contact--Name Reserved Institution Referred From NPI--Inst Referred From Institution Referred To NPI--Inst Referred To Last Follow-Up Hospital 2430 Following Registry NPI--Following Registry Reserved Physician--Managing NPI--Physician--Managing Physician--Follow-Up NPI--Physician--Follow-Up Physician--Primary Surg NPI--Physician--Primary Surg Physician NPI--Physician Physician NPI--Physician Reserved Text--DX Proc--PE 2520 R^ Text--DX Proc--X-ray/Scan 2530 R^ Text--DX Proc--Scopes 2540 R^ Text--DX Proc--Lab Tests 2550 R^ Text--DX Proc--Op 2560 R^ Text--DX Proc--Path 2570 R^
14 Text--Primary Site Title 2580 R^ Text--Histology Title 2590 R^ Text--Staging 2600 R^ RX Text--Surgery 2610 R^ RX Text--Radiation (Beam) 2620 R^ RX Text--Radiation Other 2630 R^ RX Text--Chemo 2640 R^ RX Text--Hormone 2650 R^ RX Text--BRM 2660 R^ RX Text--Other 2670 R^ Text--Remarks Text--Place of Diagnosis CS PreRx Tumor Size CS PreRx Extension CS PreRx Tum Sz/Ext Eval CS PreRx Lymph Nodes CS PreRx Reg Nodes Eval CS PreRx Mets at DX CS PreRx Mets Eval CS PostRx Tumor Size CS PostRx Extension CS PostRx Lymph Nodes CS PostRx Mets at DX CS Tumor Size 2800 R CS Extension 2810 R+ CS Tumor Size/Ext Eval 2820 R+ CS Lymph Nodes 2830 R+ CS Lymph Nodes Eval 2840 R* CS Mets at DX 2850 R+ CS Mets at Dx-Bone CS Mets at Dx-Brain CS Mets at Dx-Liver CS Mets at Dx-Lung CS Mets Eval 2860 R*
15 CS Site-Specific Factor RS* CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Version Input Original 2935 R CS Version Derived 2936 R+ CS Version Input Current 2937 R Derived AJCC-6 T Derived AJCC-6 T Descript Derived AJCC-6 N Derived AJCC-6 N Descript Derived AJCC-6 M Derived AJCC-6 M Descript 2990.
16 Derived AJCC-6 Stage Grp Derived SS Derived SS D+ Derived AJCC--Flag Derived SS1977--Flag Derived SS2000--Flag 3050 D+ Archive FIN NPI--Archive FIN Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication ICD Revision Comorbid 3165 RX Date Most Defin Surg 3170 RX Date Mst Defn Srg Flag 3171 RX Date Surgical Disch 3180 RX Date Surg Disch Flag 3181 Readm Same Hosp 30 Days 3190 Rad--Boost RX Modality 3200 Rad--Boost Dose cgy 3210 RX Date Radiation Ended 3220 RX Date Rad Ended Flag 3221 RX Date Systemic 3230 RX Date Systemic Flag 3231 RX Summ--Transplnt/Endocr 3250 RS Pain Assessment 3260 RX Summ--Palliative Proc 3270 RX Hosp--Palliative Proc 3280
17 RuralUrban Continuum D RuralUrban Continuum D Derived AJCC-7 T 3400 D* Derived AJCC-7 T Descript 3402 D* Derived AJCC-7 N 3410 D* Derived AJCC-7 N Descript 3412 D* Derived AJCC-7 M 3420 D* Derived AJCC-7 M Descript 3422 D* Derived AJCC-7 Stage Grp 3430 D* Derived PreRx-7 T 3440 Derived PreRx-7 T Descrip 3442 Derived PreRx-7 N 3450 Derived PreRx-7 N Descrip 3452 Derived PreRx-7 M 3460 Derived PreRx-7 M Descrip 3462 Derived PreRx-7 Stage Grp 3470 Derived PostRx-7 T 3480 Derived PostRx-7 N 3482 Derived PostRx-7 M 3490 Derived PostRx-7 Stge Grp 3492 Derived Neoadjuv Rx Flag 3600 SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R
18 Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Secondary Daignosis Comorbidity ICD-10-CM codes Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Report Number Path Report Number Path Report Number Path Report Number Path Report Number Path Order Phys Lic No
19 Path Order Phys Lic No Path Order Phys Lic No Path Order Phys Lic No Path Order Phys Lic No Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Report Type Path Report Type Path Report Type Path Report Type Path Report Type ASCR continue collecting these retired data items or AL specific item Item Number Length Position Follow-up Contact--Phone Column Tobacco History Column Alcohol History Column Family History of Cancer Column Religion Column Site of Distant Site Column Site of Distant Site Column Site of Distant Site Column Recurrence Distant Site Column Recurrence Distant Site Column
20 ASCR continue collecting these retired data items or AL specific items Name Position Item Number Length Follow-up Contact--Phone Column Tobacco History Column Alcohol History Column Family History of Cancer Column Religion Column Site of Distant Site 1 Column Site of Distant Site 2 Column Site of Distant Site 3 Column Recurrence Distant Site 1 Column Recurrence Distant Site 2 Column Recurrence Distant Site 3 Column Over-ride SS/DisMel1 Column Date of 1st Positive BX Column Date of 1st Positive BX Flag Column Code Fam Hist of CA Tobacco History Alcohol History 0 No Never Used No history of alcohol use 1 Yes Cigarette smoker, current Current use of alcohol 2 Cigar/pipe smoker, current Past history of alcohol use, does not currently use 3 Snuff /Chew/smokeless, current 4 Combination use, current 5 Previous Use 9 Unknown Unknown Unknown
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13) New Required Item by ASCR R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data NPCR Collect
More informationStandards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit
10 Record Type R R NAACCR 20 Patient ID Number R R R Reporting Registry 30 Registry Type NAACCR 35 FIN Coding System S NAACCR 37 Reserved 00 40 Registry ID S R R NAACCR 50 NAACCR Record Version R R NAACCR
More informationPathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative
GATRA 2016 Breast Case Demographics Name: Autumn Leaf Sex: F Date of Birth: 3/26/75 SSN: 098765432 Race: African American Marital Status: Single Address: 3615 Burnt Hickory Trail, Helen, GA 37285, White
More information2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010
2010 Cancer Data Collection Updates: Standards Volume II, Version 12 NAACCR 2009 2010 Webinar Series Introduction What s New for 2010 Record length and record layout New/changed data items Multiple Primary
More information1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
More information1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
More informationRequirements for Abstracted Text
Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation
More informationI.2 CNExT This section was software specific and deleted in 2008.
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
More informationThe Components of an Abstract. Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018
The Components of an Abstract Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018 1 Abstracts Should Tell A Story 2 The Components of an Abstract Who
More informationNCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions
NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without
More informationFORDS. Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002)
FORDS Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002) Includes updates to May 1, 2010 See Appendix C for a summary of changes.
More informationAlternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column #
RESERVED 04 750 46 482-527 RESERVED 05 1180 50 705-754 RESERVED 06 1190 45 943-987 RESERVED 07 1300 50 1065-1114 RESERVED 08 1650 50 1244-1293 RESERVED 09 1740 50 1397-1446 RESERVED 10 1835 50 2415-2464
More informationQUICK-START GUIDE NCDB Participant Use File (NCDB PUF)
QUICK-START GUIDE 2015 NCDB Participant Use File (NCDB PUF) The data included in this zipped file are provided in a flat text file format, and should be read with software such as SAS, SPSS (PASW), STATA,
More informationCCARM. Cancer Collection and Reporting Manual Revised for 2016
This publication was supported by cooperative agreement N.C. U55CCU421885 awarded to the from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and
More informationAbstract Code Manual
16th Edition Abstract Code Manual MISSOURI CANCER REGISTRY AND RESEARCH CENTER University of Missouri Columbia 2016 Revised Missouri Cancer Registry and Research Center Abstract Code Manual 16th Edition
More informationAbstracting and Coding Boot Camp: Cancer Case Scenarios
NAACC R 2015-2016 Webinar Series Abstracting and Coding Boot Camp: Cancer Case Scenarios NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org
More informationON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE
ON-LINE REGISTRATION FOR THE FCDS ANNUAL CONFERENCE, JULY 27-28, 2006, AND BROCHURE FCDS 2006 IMPLEMENTATION GUIDE FOR NAACCR VERSION 11 (REVISED 5/22/2006; ADDS NEW AND UPDATED EDITS FOR CASES RECEIVED
More informationNorth American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2018 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 18,
More informationQ: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.
Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were
More information2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?
2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? SESSION 2 10/20/17 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session, the Q&A,
More informationCERVIX MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve
More informationNorth American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2016 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 16,
More informationQ&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
More informationNorth American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2015 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 15,
More informationSetting the stage for change: upgrading the physician cancer case reporting application in New York
Setting the stage for change: upgrading the physician cancer case reporting application in New York April Austin New York State Cancer Registry (NYSCR) July 12, 2018 June 13, 2018 Aerial view of Thousand
More informationAmerican College of Surgeons 2014 Content cannot be reproduced or repurposed without written permission of the American College of Surgeons.
Revision of the FORDS Manual: A Process Dependent on Registrar and Clinician Input Frederick L. Greene, MD FACS Medical Director, Cancer Data Services, Levine Cancer Institute, Charlotte, NC 1 2 Disease
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I SUMMARY OF YEAR 2004 DATA CHANGES This document will provide a summary
More informationCommission on Cancer Updates
Commission on Cancer Updates OBJECTIVES PROVIDE CANCER REGISTRARS WITH INFORMATION ABOUT CURRENT COC 2018 CHANGES DISCUSS CHANGES RELATED TO CANCER REGISTRY DATA COLLECTION DISCUSS CHANGES RELATED TO CANCER
More informationFCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data
FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data 2011 FCDS Educational Webcast Series Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR August 18, 2011 CDC-NPCR
More informationDonna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry
Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry April 2015 2015 Data Changes New Data Items Revised Data Items ICD-0-3 Reportability Change New ICDO Terms and Codes SEER
More informationNAACR Treatment Webinar Quiz 1
NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.
More informationWho What When Where Why. Case Finding 5 W s. NAACCR Webinar Series. Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC
Who What When Where Why Case Finding 5 W s NAACCR 2010-2011 Webinar Series Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC Agenda Case Finding Purpose Reportable lists Benign intracranial
More informationPart VIII Entering Information Into the Urology Report Form
North Carolina Central Cancer Registry Instructions and Reporting Requirements Module 8 Electronic Reporting For Urology Physician Practices May 2013 North Carolina Central Cancer Registry State Center
More informationMCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR
MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and
More informationStandards for Cancer Registries, Volume I. Data Exchange Standards and Record Descriptions
Standards for Cancer Registries, Volume I Data Exchange Standards and Record Descriptions Version 18 March 2018 Edited by Lori A. Havener, CTR Program Manager of Standards North American Association of
More informationAJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer
More informationFORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute
FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute Charlotte, NC National Accreditation Program for Breast
More information2018 New Required Data Items for Hospitals
2018 New Required Data Items for Hospitals The NJSCR is a population-based registry, mandated by state law, that collects data on all cancer cases diagnosed and/or treated in New Jersey since October 1,
More informationMichigan Cancer Surveillance Program
Michigan Cancer Surveillance Program Supplemental Guidance for the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA)
More information7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+
2014 Grade Coding Instructions ICD-O-3 Updates 1 I M P L E M E N T A T I O N T I M E L I N E ( S ) 2 0 1 4 F C D S D A M A P P E N D I X H A N D O U T S F C D S A N N U A L C O N F E R E N C E O R L A
More informationVISUAL EDITING GUIDELINES March 2015 (revised June 2015)
March 2015 (revised June 2015) Developed for The Cancer Registry of Greater California under the direction of Winny Roshala, BA, CTR, Data Quality Control Director By the following contributing Authors:
More informationCancer Registry Abstracting FLORIDA CANCER DATA SYSTEM
Cancer Registry 1 Learning Objectives 2 Integrate previously learned principles of cancer identification (anatomy, casefinding, site and histology identification principles, staging principles, and treatment
More information4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines
SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific
More informationNAACCR Webinar Series 1
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar
More information7/29/2014. Patterns of Care in Colon Cancer ( ) Literature. Background. Florida Cancer Data Compliance with NCCN Guidelines
Patterns of Care in Colon Cancer (21-212) Florida Cancer Data Compliance with FCDS Annual Meeting July 24-25, 214 Caribe Royale Resort Orlando, Florida Background O NCCN guidelines are referenced extensively
More information2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights
F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014-2015 FCDS Webcast Series Steven Peace, CTR August 21, 2014 2014 FCDS Annual
More informationCancer Data Uses and Dissemination. State of the State Florida Cancer Data System /21/2014. Certification. Presentation Outline
F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014 FCDS Annual Conference Recordings & Handouts http://fcds.med.miami.edu/inc/educationtraining.shtml
More informationThe New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards
More informationNAACCR Webinar 2018 SeriesImplementations and Timelines
NAACCR 2015-2016 Webinar 2018 SeriesImplementations and Timelines August 8, 2017 Session 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session,
More information10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards,
2 013-2014 QUALITY IMPROVEMENT EDUCATION AND TRAINING NCRA CEU # 2013-114 Continuing Education Hours Date Event Sponsor 7/25/2013-7/26/2013 CEU Hrs FCDS Annual Conference, Sunrise, FL FCDS 8.25 2013-115
More informationNPCR s TNM Stage Calculator
NPCR s TNM Stage Calculator A Tool for Central Registry Quality Control and Consolidation Assistance NAACCR Annual Meeting June 16, 2016 Jennifer Seiffert Northrop Grumman Under contract to NPCR Joseph
More informationStage Data Capture in Ontario
Stage Data Capture in Ontario February 23, 2010 Agenda Refresher: Ontario s Stage Capture Project Collaborative Staging and Population Stage Reporting in Ontario Use of Stage Data in System Performance
More informationEVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
More informationCanadian Cancer Registry Reference Guide For Years
Canadian Cancer Registry Reference Guide For Years 2000-2015 Compiled by: Edna Kalu, Zikuan Liu HOW TO OBTAIN MORE INFORMATION For more information about this guide or other services and data available
More informationData Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data,
Data Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data, 2004-2012 Jeanne Whitlock, MSLS, CTR Julie George, MS Ron Shore, MPH Fawn D. Vigneau, JD, MPH Metropolitan
More informationNewton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
More informationGeneral Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators
American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.
More informationCancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff
More information1 : Patient Details. 2 : Medical Aid Details. 3 : Practitioner Detail (Practice) 4 : Patient History
1 : Patient Details Surname: Firstname: Initials: ID Number: First Diagnosed: Gender: Telephone: CellPhone: Dependant Code: Birth: Postal Address Fax: Email: 2 : Medical Aid Details Principal Member: Membership
More informationCollecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009
Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series
More informationNorth American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) Death Clearance Manual Minimum Requirements and Best Practices for Conducting Death Clearance Effective January 1, 2015 for Deaths
More informationInteractive Discussion of Part I CS Coding Instructions: Working the Cases
Interactive Discussion of Part I CS Coding Instructions: Working the Cases April Fritz, RHIT, CTR Donna M. Gress, RHIT, CTR Jennifer Ruhl, RHIT, CCS, CTR This presentation was supported by the Cooperative
More informationThe Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study
The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study Robert R. German, DrPH, MPH; Tim Byers, MD, MPH; Holly Wolf, PhD, MSPH; Jen Wike, MBA, MPH; Linda Alley,
More informationCancer as a Disease. Linda D. Rego, CTR March 2009
Cancer as a Disease Linda D. Rego, CTR March 2009 Historic perspective First records date as early as 2500 B.C. In Egypt recorded on papyrus Outlines pharmacological, mechanical and magical treatments
More informationNPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
More informationExplaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging
Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement
More informationNAACCR 2018 IMPLEMENTATION WEBINAR
If you experience technical difficulties, Please call us at 217 698 0800 x 111 NAACCR 2018 IMPLEMENTATION WEBINAR NAACCR 2018 IMPLEMENTATION WG DECEMBER 18, 2017 HOUSEKEEPING We will address all questions
More information5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry
AJCC Stage Introduction and General Rules Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationFlorida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
More informationExplaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging
Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement
More informationCollecting Cancer Data: Pancreas
Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this
More informationAJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by
AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast
Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More information12/10/2012 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS. Continuing Education Hours. Presentation Outline
IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS FCDS Webcast Series Steven Peace, BS, CTR December 13, 2012 2 Continuing Education Hours NCRA CEU # 2012-065 Date(s)
More information12/10/2012. Continuing Education Hours IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS
2 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS NCRA CEU # 2012-065 Continuing Education Hours Date(s) Event 7/26/2012-7/27/2012 2012-155 8/16/2012 Spons or FCDS
More informationA CENTRAL REGISTRY RELIABILITY STUDY
A CENTRAL REGISTRY RELIABILITY STUDY Visual Editor TNM & Summary Stage Staging Skill Assessment Donna M. Hansen, CTR Auditor & Education Training Coordinator California Cancer Registry NAACCR June 16,
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationAJCC TNM 6 th Edition Staging Input Data Dictionary
Catalogue no. 82-225-XIE No. 001 ISSN: 1715-2100 O ISBN: 0-662-41801-8 Manuals AJCC TNM 6 th Edition Staging Input Data Dictionary by Michel Cormier Health Statistics Division Client Custom Services Room
More informationARDS. of the Commission on Cancer. Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98
STAND ANDARDS ARDS of the Commission on Cancer Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98 1998 Commission on Cancer, American College of Surgeons Commission on Cancer 633
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More informationThe Commission on Cancer: Reengineering the National Cancer Data Base
The Commission on Cancer: Reengineering the National Cancer Data Base Stephen B. Edge MD FACS Chair Commission on Cancer American College of Surgeons Alfiero Chair of Breast Oncology Professor of Surgery
More informationACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationUtilization of OncoType DX Test for
Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy
More informationCase Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.
More informationLesson 8 Classifications
Lesson 8 Classifications Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease
More informationWeb Plus Instructions Radiation CCR
Web Plus Instructions Radiation CCR To begin entering Abstracts through Web Plus, you must first log into https://webplus.njscr.org/webplus/logonen.aspx with credentials that are provided to you once your
More informationFactors Associated with Initial Treatment for Clinically Localized Prostate Cancer
Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Preliminary Results from the National Program of Cancer Registries Patterns of Care Study (PoC1) NAACCR Annual Meeting
More informationKidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification
Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification A1: Yes. See below. I don't think it will have a start date. Clarification
More informationCase Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
More informationIntroduction & Descriptors
AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationPancreas Case Scenario #1
Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass
More informationThe Impact of E-Path Technology on the Ontario Cancer Registry. Operations
The Impact of E-Path Technology on the Ontario Cancer Registry Pathology LIS Operations Presented at the NAACCR 2002 Cancer Informatics Workshop Toronto, Ontario June 2002 EDI Darlene Dale Manager, Ontario
More informationWhat s New in 2012 FCDS Annual Meeting Review
What s New in 2012 FCDS Annual Meeting Review FCDS Educational Webcast Series August 16, 2012 FCDS Staff Steven Peace, CTR 2012 FORDS Cancer Program Standards CSv02.04 1 What is Cancer / What is Reportable
More informationFCDS TENTATIVE V11 TO V11.1 IMPLEMENTATION SCHEDULE
NAACCR V11.1 UPDATES ZIP CODE, FIPS COUNTY, FLORIDA CITY NAME VERIFICATION FILE (COMMA SEPARATED TEXT FILE) CANCER TRAINING: PRINCIPLES AND PRACTICE OF CANCER REGISTRATION, SURVEILLANCE AND CONTROL, JULY
More information2018 Updates to National Standards
2018 Updates to National Standards 1 F C D S A N N U A L C O N F E R E N C E O R L A N D O, F L O R I D A 7 / 2 6 / 2 0 1 7 S T E V E N P E A C E, C T R ICD-O-3 New Histology Codes ICD-O-3 Behavior Changes
More informationCancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
MEASURE SPECIFICATIOS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) ational Cancer Data Base (CDB) staff has undertaken
More informationThe Death Clearance Process: What Do We Gain From Our Efforts?
The Death Clearance Process: What Do We Gain From Our Efforts? Colleen G. Sherman Maria J. Schymura April A. Austin Baozhen Qiao NAACCR 2012 Objectives Demonstrate the variability of resolution from follow
More information